SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-159375
Filing Date
2018-05-10
Accepted
2018-05-10 17:18:06
Documents
81
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d537374d10q.htm 10-Q 822562
2 EX-10.6 d537374dex106.htm EX-10.6 25307
3 EX-10.7 d537374dex107.htm EX-10.7 117562
4 EX-31.1 d537374dex311.htm EX-31.1 9852
5 EX-31.2 d537374dex312.htm EX-31.2 9860
6 EX-32.1 d537374dex321.htm EX-32.1 3585
7 EX-32.2 d537374dex322.htm EX-32.2 3552
14 GRAPHIC g53737482.gif GRAPHIC 3588
  Complete submission text file 0001193125-18-159375.txt   5180249

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT eypt-20180331.xml EX-101.INS 794821
9 XBRL TAXONOMY EXTENSION SCHEMA eypt-20180331.xsd EX-101.SCH 69168
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eypt-20180331_cal.xml EX-101.CAL 60190
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eypt-20180331_def.xml EX-101.DEF 295678
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE eypt-20180331_lab.xml EX-101.LAB 513881
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eypt-20180331_pre.xml EX-101.PRE 428084
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-51122 | Film No.: 18824046
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10